首页|期刊导航|中医学报(英文)|抗抑郁药物在乳腺癌治疗中的应用研究进展

抗抑郁药物在乳腺癌治疗中的应用研究进展OA

Research Progress on the Application of Antidepressants in Breast Cancer Treatment

中文摘要英文摘要

抑郁症与乳腺癌在临床常常成为共病,二者相互影响交恶,形成恶性循环并加速疾病进展.中医理论认为,肝郁气滞、痰瘀互结是乳腺癌和抑郁症的共同病机.大量研究发现,多种抗抑郁药物不仅可改善乳腺癌患者的情绪障碍,还可通过多种机制发挥协同抗乳腺癌作用,同时有效缓解抗肿瘤治疗所致的不良反应.本文通过系统梳理国内外相关研究进展,总结了常用抗抑郁药物在乳腺癌治疗中的临床应用价值和作用机制,并分析其临床优势和局限性;同时归纳以逍遥散为代表的疏肝解郁类方以及黄芩苷、姜黄素等天然活性成分的抗抑郁和抗肿瘤双重功效,旨在为乳腺癌合并抑郁共病的中西医结合综合干预、靶向联合治疗策略优化、新型辅助治疗药物研发提供理论参考与新思路.

Depression frequently co-occurs with breast cancer in clinical practice,and the two conditions interact reciprocally to form a vicious cycle that accelerates disease progression.Traditional Chinese medicine(TCM)theory holds that liver qi stagnation intermingled with phlegm and blood stasis constitutes the shared pathogenesis of breast cancer and depression.Accumulating studies have demonstrated that various antidepressants not only alleviate emotional disorders in breast cancer patients but also exert synergistic anti-breast cancer effects through multiple mechanisms,as well as effectively alleviate adverse reactions induced by antitumor therapies.This paper systematically reviews domestic and international research progress,summarizes the clinical application value and action mechanisms of commonly used antidepressants in breast cancer management,and analyzes their clinical advantages and limitations.Meanwhile,it summarizes the dual antidepressant and antitumor efficacy of liver-soothing and depression-relieving formulas represented byXiaoyao San,together with natural active components such as baicalin and curcumin.This review aims to provide theoretical references and novel perspectives for integrated traditional Chinese and Western medicine comprehensive intervention,optimization of targeted combination therapy strategies,and research and development of novel adjuvant therapeutic agents for patients with comorbid breast cancer and depression.

牛站营;王艺淇;栗敏;栗俞程

河南中医药大学第五临床医学院,河南郑州河南中医药大学第五临床医学院,河南郑州河南中医药大学第五临床医学院,河南郑州河南中医药大学中医药科学院,河南郑州

抗抑郁药乳腺癌药物重定位作用机制

antidepressantsbreast cancerdrug repurposingaction mechanism

《中医学报(英文)》 2026 (3)

186-193,中插38-中插46,17

This work was supported by the Zhengzhou Municipal Science and Technology Innovation Program for Medical and Health Fields(2025YLZDJH279). 郑州市医疗卫生领域科技创新计划项目(2025YLZDJH279)

10.1055/a-2943-5227

评论